Does ABATACEPT Cause Gastrointestinal carcinoma? 25 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Gastrointestinal carcinoma have been filed in association with ABATACEPT (ORENCIA). This represents 0.0% of all adverse event reports for ABATACEPT.
25
Reports of Gastrointestinal carcinoma with ABATACEPT
0.0%
of all ABATACEPT reports
3
Deaths
13
Hospitalizations
How Dangerous Is Gastrointestinal carcinoma From ABATACEPT?
Of the 25 reports, 3 (12.0%) resulted in death, 13 (52.0%) required hospitalization, and 2 (8.0%) were considered life-threatening.
Is Gastrointestinal carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ABATACEPT. However, 25 reports have been filed with the FAERS database.
What Other Side Effects Does ABATACEPT Cause?
Drug ineffective (35,212)
Rheumatoid arthritis (21,898)
Pain (19,783)
Arthralgia (18,536)
Joint swelling (18,453)
Contraindicated product administered (13,559)
Fatigue (13,087)
Drug intolerance (12,451)
Rash (12,168)
Arthropathy (11,099)
What Other Drugs Cause Gastrointestinal carcinoma?
RANITIDINE (6,475)
ADALIMUMAB (142)
INFLIXIMAB (96)
CLOZAPINE (73)
VEDOLIZUMAB (54)
USTEKINUMAB (47)
ETANERCEPT (43)
LEUPROLIDE (41)
OCTREOTIDE (36)
RISANKIZUMAB-RZAA (35)
Which ABATACEPT Alternatives Have Lower Gastrointestinal carcinoma Risk?
ABATACEPT vs ABATACEPT SUBQ /ML
ABATACEPT vs ABCIXIMAB
ABATACEPT vs ABEMACICLIB
ABATACEPT vs ABILIFY
ABATACEPT vs ABIRATERONE